173 related articles for article (PubMed ID: 29311298)
1. IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways.
Song NY; Zhu F; Wang Z; Willette-Brown J; Xi S; Sun Z; Su L; Wu X; Ma B; Nussinov R; Xia X; Schrump DS; Johnson PF; Karin M; Hu Y
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E812-E821. PubMed ID: 29311298
[TBL] [Abstract][Full Text] [Related]
2. IκB Kinase α Is Required for Development and Progression of
Vreka M; Lilis I; Papageorgopoulou M; Giotopoulou GA; Lianou M; Giopanou I; Kanellakis NI; Spella M; Agalioti T; Armenis V; Goldmann T; Marwitz S; Yull FE; Blackwell TS; Pasparakis M; Marazioti A; Stathopoulos GT
Cancer Res; 2018 Jun; 78(11):2939-2951. PubMed ID: 29588349
[TBL] [Abstract][Full Text] [Related]
3. The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.
Yang H; Xiang S; Kazi A; Sebti SM
J Biol Chem; 2020 Mar; 295(10):3055-3063. PubMed ID: 32001619
[TBL] [Abstract][Full Text] [Related]
4. Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.
Wang Y; Hou N; Cheng X; Zhang J; Tan X; Zhang C; Tang Y; Teng Y; Yang X
Int J Biol Sci; 2017; 13(5):652-659. PubMed ID: 28539837
[TBL] [Abstract][Full Text] [Related]
5. IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.
Song NY; Li X; Ma B; Willette-Brown J; Zhu F; Jiang C; Su L; Shetty J; Zhao Y; Shi G; Banerjee S; Wu X; Tran B; Nussinov R; Karin M; Hu Y
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35121655
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
7. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis.
Xie CM; Wei D; Zhao L; Marchetto S; Mei L; Borg JP; Sun Y
J Cell Biol; 2015 Jun; 209(5):721-37. PubMed ID: 26056141
[TBL] [Abstract][Full Text] [Related]
8. Role of PTEN in basal cell derived lung carcinogenesis.
Malkoski SP; Cleaver TG; Thompson JJ; Sutton WP; Haeger SM; Rodriguez KJ; Lu SL; Merrick D; Wang XJ
Mol Carcinog; 2014 Oct; 53(10):841-6. PubMed ID: 23625632
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.
Volonte D; Vyas AR; Chen C; Dacic S; Stabile LP; Kurland BF; Abberbock SR; Burns TF; Herman JG; Di YP; Galbiati F
J Biol Chem; 2018 Feb; 293(5):1794-1809. PubMed ID: 29247004
[TBL] [Abstract][Full Text] [Related]
10. NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease.
Aydin E; Hallner A; Grauers Wiktorin H; Staffas A; Hellstrand K; Martner A
Oncogene; 2019 Feb; 38(9):1534-1543. PubMed ID: 30323311
[TBL] [Abstract][Full Text] [Related]
11. The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy.
Ferino A; Rapozzi V; Xodo LE
J Photochem Photobiol B; 2020 Jan; 202():111672. PubMed ID: 31778952
[TBL] [Abstract][Full Text] [Related]
12. The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1.
Meijles DN; Sahoo S; Al Ghouleh I; Amaral JH; Bienes-Martinez R; Knupp HE; Attaran S; Sembrat JC; Nouraie SM; Rojas MM; Novelli EM; Gladwin MT; Isenberg JS; Cifuentes-Pagano E; Pagano PJ
Sci Signal; 2017 Oct; 10(501):. PubMed ID: 29042481
[TBL] [Abstract][Full Text] [Related]
13. Membrane-Bound CD40L Promotes Senescence and Initiates Senescence-Associated Secretory Phenotype via NF-κB Activation in Lung Adenocarcinoma.
Xu W; Li Y; Yuan WW; Yin Y; Song WW; Wang Y; Huang QQ; Zhao WH; Wu JQ
Cell Physiol Biochem; 2018; 48(4):1793-1803. PubMed ID: 30078020
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors.
Baek KH; Bhang D; Zaslavsky A; Wang LC; Vachani A; Kim CF; Albelda SM; Evan GI; Ryeom S
J Clin Invest; 2013 Oct; 123(10):4375-89. PubMed ID: 24018559
[TBL] [Abstract][Full Text] [Related]
15. Sirt3 is a tumor suppressor in lung adenocarcinoma cells.
Xiao K; Jiang J; Wang W; Cao S; Zhu L; Zeng H; Ouyang R; Zhou R; Chen P
Oncol Rep; 2013 Sep; 30(3):1323-8. PubMed ID: 23842789
[TBL] [Abstract][Full Text] [Related]
16. EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect.
Sahnane N; Frattini M; Bernasconi B; Zappa F; Schiavone G; Wannesson L; Antonelli P; Balzarini P; Sessa F; Mazzucchelli L; Tibiletti MG; Martin V
Clin Lung Cancer; 2016 Jan; 17(1):56-61. PubMed ID: 26381283
[TBL] [Abstract][Full Text] [Related]
17. Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
Yeddula N; Xia Y; Ke E; Beumer J; Verma IM
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6476-85. PubMed ID: 26542681
[TBL] [Abstract][Full Text] [Related]
18. p53 loss does not permit escape from Braf
Garnett S; Dutchak KL; McDonough RV; Dankort D
Oncogene; 2017 Nov; 36(45):6325-6335. PubMed ID: 28745322
[TBL] [Abstract][Full Text] [Related]
19. CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation.
Chavdoula E; Habiel DM; Roupakia E; Markopoulos GS; Vasilaki E; Kokkalis A; Polyzos AP; Boleti H; Thanos D; Klinakis A; Kolettas E; Marcu KB
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31792060
[TBL] [Abstract][Full Text] [Related]
20. Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias.
Kohno T; Kunitoh H; Suzuki K; Yamamoto S; Kuchiba A; Matsuno Y; Yanagitani N; Yokota J
Carcinogenesis; 2008 May; 29(5):957-63. PubMed ID: 18299280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
